Corticosteroids, optic neuritis, and multiple sclerosis
Hart, R.G.
New England Journal of Medicine 330(17): 1238-1239
1994
ISSN/ISBN: 0028-4793 PMID: 8139644 Accession: 045658987
Full Text Article emailed within 1 workday: $29.90
Related References
Beck, R.W.; Cleary, P.A.; Trobe, J.D.; Kaufman, D.I.; Kupersmith, M.J.; Paty, D.W.; Brown, C.H. 1993: The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group New England Journal of Medicine 329(24): 1764-1769Olek, M.J.; Khan, O.A. 1994: Corticosteroids, optic neuritis, and multiple sclerosis New England Journal of Medicine 330(17): 1238; Author Reply 1239
Elovaara, I.; Pirttilä, T. 2000: Corticosteroids in the treatment of multiple sclerosis and optic neuritis Duodecim; Laaketieteellinen Aikakauskirja 116(15): 1547-1554
Dr James Goodwin 1996: High Dosage Corticosteroids in the Treatment of Optic Neuritis and Prophylaxis of Multiple Sclerosis Biodrugs 6(5): 405-412
Beck, R.W.; Cleary, P.A.; Trobe, J.D.; Kaufman, D.I.; Kupersmith, M.J.; Paty, D.W.; Brown, C.H. 1993: The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis The new England Journal of Medicine 329(24): 1764-1769
2003: High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: Experience of the optic neuritis treatment trial Archives of Ophthalmology (1960) 121(7): 944-949
Beck, R.W.; Trobe, J.D.; Moke, P.S.; Gal, R.L.; Xing, D.; Bhatti, M.Tariq.; Brodsky, M.C.; Buckley, E.G.; Chrousos, G.A.; Corbett, J.; Eggenberger, E.; Goodwin, J.A.; Katz, B.; Kaufman, D.I.; Keltner, J.L.; Kupersmith, M.J.; Miller, N.R.; Nazarian, S.; Orengo-Nania, S.; Savino, P.J.; Shults, W.T.; Smith, C.H.; Wall, M. 2003: High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial Archives of Ophthalmology 121(7): 944-949
Luo, W.; Deng, X.; Xu, X.; Song, R.; Luo, M.; Moss, H.E.; Du, Y. 2022: Development of a Prognostic Model for Predicting Multiple Sclerosis After Optic Neuritis: a Secondary Analysis of Data from the Optic Neuritis Treatment Trial Journal of Neuro-Ophthalmology: the Official Journal of the North American Neuro-Ophthalmology Society 42(1): 88-96
Sergott, R.C. 2009: Multiple Sclerosis Risk After Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-up Yearbook of Ophthalmology 2009: 187-188
Brodsky, M.; Nazarian, S.; Orengo-Nania, S.; Hutton, G.J.; Buckley, E.G.; Massey, E.Wayne.; Bhatti, M.Tariq.; Greer, M.; Goodwin, J.; Wall, M.; Savino, P.J.; Leist, T.; Miller, N.R.; Irani, D.; Trobe, J.D.; Cornblath, W.; Kaufman, D.I.; Eggenberger, E.; Kupersmith, M.J.; Shults, W.T.; McAllister, L.; Hamilton, S.; Beck, R.W.; Dontchev, M.; Gal, R.L.; Kollman, C.; Keltner, J.L.; Smith, C.H. 2008: Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up Archives of Neurology 65(6): 727-732
Liutkevičienė, R.; Vilkevičiūtė, A.; Banevičus, M.; Miežytė, R.; Kriaučiūnienė, L. 2018: Association of MMP-2 (⁻1306 C/T) Gene Polymorphism with Predisposition to Optic Neuritis and Optic Neuritis Together with Multiple Sclerosis Medicina 54(2)
Samsen, P.; Chuenkongkaew, W.L.; Masayaanon, P.; Chirapapaisan, N.; Ruangvaravate, N.; Loket, S. 2007: A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis Journal of the Medical Association of Thailand 90(2): 313-318
Samsen, P.; Chuenkongkaew, W.L.; Masayaanon, P.; Chirapapaisan, N.; Ruangvaravate, N.; Loket, S. 2007: A Comparative Study of Visual Evoked Potentials in Optic Neuritis and Optic Neuritis with Multiple Sclerosis Chot Mai het Thang Phaet 90(2): 315-320
Wilson, W.B. 1978: Visual-evoked response differentiation of ischemic optic neuritis from the optic neuritis of multiple sclerosis American Journal of Ophthalmology 86(4): 530-535
Tumani, H.; Tourtellotte, W.W.; Peter, J.B.; Felgenhauer, K. 1998: Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. the Optic Neuritis Study Group Journal of the Neurological Sciences 155(1): 44-49
Hutchinson, W.M.; Haire, M. 1976: Measles-virus-specific IgG in optic neuritis and in multiple sclerosis after optic neuritis British Medical Journal 1(6001): 64-66
Park, K.-A.; Kim, J.; Oh, S.Y. 2014: Analysis of spectral domain optical coherence tomography measurements in optic neuritis: differences in neuromyelitis optica, multiple sclerosis, isolated optic neuritis and normal healthy controls Acta Ophthalmologica 92(1): E57-E65
Chen, J.J.; Sotirchos, E.S.; Henderson, A.D.; Vasileiou, E.S.; Flanagan, E.P.; Bhatti, M.T.; Jamali, S.; Eggenberger, E.R.; Dinome, M.; Frohman, L.P.; Arnold, A.C.; Bonelli, L.; Seleme, N.; Mejia-Vergara, A.J.; Moss, H.E.; Padungkiatsagul, T.; Stiebel-Kalish, H.; Lotan, I.; Hellmann, M.A.; Hodge, D.; Oertel, F.C.; Paul, F.; Saidha, S.; Calabresi, P.A.; Pittock, S.J. 2022: OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS Multiple Sclerosis and Related Disorders 58: 103525
Ko, M; Chaudhry, F; Hickman, S J.; Jay, W M. 2009: Optic Neuritis: An Update. II. Optic Neuritis and Multiple Sclerosis Neuro-Ophthalmology 33(1-2): 10-22
Ohlenbusch, A.; Wilichowski, E.; Hanefeld, F. 1998: Characterization of the mitochondrial genome in childhood multiple sclerosis. III. Multiple sclerosis without optic neuritis and the non-LHON-associated genes Neuropediatrics 29(6): 313-319